Résumé
Nucleophosmin (NPM1) is frequently mutated or subjected to chromosomal translocation in acute myeloid leukemia (AML). NPM protein is primarily located in the nucleus, but the recurrent NPMc+ mutation, which creates a nuclear export signal, is characterized by cytoplasmic localization and leukemogenic properties. Similarly, the NPM-MLF1 translocation product favors the partial cytoplasmic retention of NPM. Regardless of their common cellular distribution, NPM-MLF1 malignancies engender different effects on hematopoiesis compared to NPMc+ counterparts, highlighting possible aberrant nuclear function(s) of NPM in NPMc+ and NPM-MLF1 AML. We performed a proteomic analysis and found that NPM and NPM-MLF1 interact with various nuclear proteins including subunits of the chromatin remodeling complexes ISWI, NuRD and P/BAF. Accordingly, NPM and NPM-MLF1 are recruited to transcriptionally active or repressed genes along with NuRD subunits. Although the overall gene expression program in NPM knockdown cells is similar to that resulting from NPMc +, NPM-MLF1 expression differentially altered gene transcription regulated by NPM. The abnormal gene regulation imposed by NPM-MLF1 can be characterized by the enhanced recruitment of NuRD to gene regulatory regions. Thus, different mechanisms would orchestrate the dysregulation of NPM function in NPMc+- versus NPM1-MLF1-associated leukemia.
Langue d'origine | English |
---|---|
Numéro d'article | e1008463 |
Journal | PLoS Genetics |
Volume | 15 |
Numéro de publication | 11 |
DOI | |
Statut de publication | Published - 2019 |
Note bibliographique
Funding Information:This work was supported by an Operating Grant from the Canadian Institute of Health Research [CIHR; grant number: MOP 126009 to EM]; and by a Discovery Grant from the Natural Sciences and Engineering Research Council [NSERC; grant number: RGPIN-2015-05381 to EBA]; AD was supported by the doctoral training awards from the 'Programme Biologie Moléculaire' and the FES, Université de Montréal; EBA is a senior scholar of Le Fonds de la Recherche du Québec en Santé (FRQ-S). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We thank Dr M. Buscarlet and M. Larivière for guidance with the AmpliSeq procedure; Dr SW. Morris for providing us with the NPM-MLF1 cDNA; Drs E. Drobetsky, S. Bottardi and M. Dubuissez for critical reading of the manuscript.
Publisher Copyright:
© 2019 Darracq et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
ASJC Scopus Subject Areas
- Ecology, Evolution, Behavior and Systematics
- Molecular Biology
- Genetics
- Genetics(clinical)
- Cancer Research
PubMed: MeSH publication types
- Journal Article
- Research Support, Non-U.S. Gov't